跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-APIXABAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-APIXABAN
Authorized
STANDARD
TEVA-APIXABAN
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f0560bef8e3c10b1
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
f0560bef8e3c10b1
Drug Approval Canada Name
TEVA-APIXABAN
Product Name
TEVA-APIXABAN
Status
Marketed
Status Date
2023-09-22
Original Market Date
2023-09-22
Din
02484994
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
20:12.04.14
Atc Original
B01AF02 APIXABAN
Atc Name
b 01 af 02
Aig Number
0153051001
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
APIXABAN
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f0560bef8e3c10b1
Type
Standard
Back to Health Canada Approvals